PDF(Pubmed)
Abstract：
In the late nineties, polyacrylamide gel (PAAG) gained popularity in China as a soft tissue filler for breast augmentation and contouring, but was banned 10 years later due to the increasing incidence of complications. We report a case of PAAG complication that occurred 20 years after the initial injection, where the patient had significant unilateral breast swelling and an intracapsular lesion. Surgical removal of the breast filler and immediate breast reconstruction was successfully performed, and histology confirmed a benign breast lesion. These findings highlight the importance of clinical awareness of PAAG breast filler complications.
摘要：
在九十年代末，聚丙烯酰胺凝胶（PAAG）在中国作为隆胸和轮廓的软组织填充剂而受到欢迎，但10年后由于并发症发生率的增加而被禁止。我们报告一例PAAG并发症发生在初次注射后20年，患者有明显的单侧乳房肿胀和囊内病变。成功进行了乳房填充物的手术切除和立即乳房重建，组织学证实乳腺良性病变。这些发现强调了临床认识PAAG乳房填充物并发症的重要性。
